Michael Hamblin on Muck Rack

Michael Hamblin

Melrose
As seen in: Arthritis & Rheumatology, Nature, Wiley Online Library, Frontiers, Taylor & Francis Online, Royal Society of Chemistry, Canadian Journal of Infectious Diseases & Medical Microbiology, Mary Ann Liebert, Inc., Psychiatric Times, Scientific Research Publishing (SCIRP) and
Michael R Hamblin was a Principal Investigator at Wellman Center for Photomedicine and is now a Distinguished Visiting Professor at University of Johannesburg
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Michael

Contact Michael, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Effects of transcranial photobiomodulation on fine motor skills in boccia para‐athletes

|
By Michael Hamblin, Aguinaldo Silva Garcez, Alessandra Baptista, Selly S. Suzuki
| Wiley Online Library
CONFLICT OF INTEREST STATEMENT No potential conflict of interest was reported by the authors. REFERENCES 1, , , et al. A novel transcranial photobiomodulation device to address motor signs of Parkinson's disease: a parallel randomised feasibility study. EClinical Medicine. 2023; 66:102338. 2. Transcranial photobiomodulation for the brain: a wide range of clinical applications. Neural Regen Res. 2024; 19: 483-484. 3, , . Parkinson's disease and Photobiomodulation: potential for treatment. J Pers Med.
Open in Who Shared Issue with article?

4-Methyllumifrone (4-MU) can improve learning and memory after cerebral ischemia/reperfusion injury in rats

|
By Shaghayegh Tamouk, Hamzeh Mirshekari jahangiri, Elham Kashafi Jahromi, Michael Hamblin
| biorxiv.org
Abstract Background: Stroke is the sixth leading cause of death and lifelong disability for millions of people in the United States. Cerebral ischemia leads to oxidative stress, excitotoxicity, inflammation, apoptosis; additionally, impairments in memory and learning occur in the majority of subjects with ischemic stroke.
Open in Who Shared Issue with article?

4-Methyllumbiferone (4-MU) exerts a neuroprotective effect against cerebral ischemia/reperfusion injury by ameliorating learning and memory impairments

|
By Michael Hamblin, Shaghayegh Tamouk, Hamzeh Mirshekari jahangiri, Elham Kashafi Jahromi
| biorxiv.org
Abstract Background: Stroke is the sixth leading cause of death and lifelong disability for millions of people in the United States. Cerebral ischemia lead to in oxidative stress, excitotoxicity, inflammation, apoptosis and also, impairments in memory and learning occur in majority of subjects with ischemic stroke.
Open in Who Shared Issue with article?
See all 25 licensed articles (27 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Michael

Contact Michael, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified